Oxford BioMedica(GB:OXB)
GBX 530.00-5.00 (-0.93%)
GB:OXB
Oxford BioMedica financials statements
GBX 530.00
At close:-5.00 (-0.93%)
Want to see GB:OXB full AI Analyst Report?
Oxford BioMedica (OXB) Income Statement
113 Followers
Oxford BioMedica Income Statement
Last quarter (Q2 2026), Oxford BioMedica's total revenue was £79.84M, an increase of 57.16% from the same quarter last year. In Q2, Oxford BioMedica's net income was £-36.96M. See Oxford BioMedica’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 168.74M | £ 128.80M | £ 89.54M | £ 139.99M | £ 142.80M | |
| £ 65.98M | £ 53.02M | £ 39.73M | £ 69.18M | £ 82.64M | |
| £ 94.95M | £ 92.40M | £ 223.90M | £ 120.74M | £ 61.71M | |
| Depreciation and Amortization | £ 20.49M | £ 22.43M | £ 28.71M | £ 26.36M | £ 12.46M |
| £ -9.12M | £ -15.00M | £ -148.62M | £ -10.86M | £ 33.22M | |
| £ -29.61M | £ -39.38M | £ -184.17M | £ -30.22M | £ 20.77M | |
| £ -2.33M | £ -7.89M | £ -4.35M | £ -15.76M | £ -888.00K | |
| £ -31.94M | £ -47.27M | £ -188.53M | £ -45.98M | £ 19.88M | |
| £ -30.13M | £ -43.19M | £ -157.49M | £ -39.16M | £ 19.01M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.27 | £ -0.42 | £ -1.63 | £ -0.41 | £ 0.23 |
| Diluted EPS | £ -0.27 | £ -0.42 | £ -1.63 | £ -0.41 | £ 0.22 |
| Weighted Average Shares Outstanding | 111.92M | 103.46M | 96.56M | 94.83M | 83.48M |
| Weighted Average Shares Outstanding (Diluted) | 111.92M | 103.46M | 96.56M | 94.83M | 85.62M |
Currency in GBP
